Local Diabetes Breakthrough May Reduce Injections To Twice A Week
Posted September 8, 2008 12:00 pm.
This article is more than 5 years old.
It’s a medical breakthrough that could lead to a big change in lifestyle for those suffering from type 2 diabetes.
Toronto researcher Dr. Daniel Drucker is touting the benefits of a new once-weekly treatment that could replace the more common twice-daily injection. “Over two million Canadians have diabetes,” said Dr. Drucker of Mount Sinai Hospital. “There is currently no available therapy for type 2 diabetes that patients can receive once a week.”
The new treatment is called Exenatide and studies have shown that those who were injected with the long-lasting drug experienced fewer side effects, no increased risk of hypoglycemia and many even reported weight loss.
The new drug could be ready for use as early as 2009.
“Biomedical research reaches patients and improves lives,” said Dr. Jim Woodgett.
“Dr. Drucker is a world-expert in the development of peptide hormone-based therapies for the treatment of human disease and this is an excellent example of moving discovery through to therapeutic application.”
For more on Type 2 diabetes, click here.
